Are blood eosinophils a prime-time biomarker for COPD management decisions?
Ioanna Tsiligianni,1 Alan G Kaplan2 1Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece; 2Family Physician Airways Group of Canada, University of Toronto, Toronto, ON, Canada COPD is a preventable and treatable disease with patients showing a great d...
Main Authors: | Tsiligianni I, Kaplan AG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-06-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/are-blood-eosinophils-a-prime-time-biomarker-for-copd-management-decis-peer-reviewed-article-COPD |
Similar Items
-
Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis
by: Cheng SL
Published: (2018-09-01) -
Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
by: Claus F. Vogelmeier, et al.
Published: (2019-08-01) -
Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma
by: Umme Kolsum, et al.
Published: (2017-04-01) -
Blood eosinophil count as a prognostic biomarker in COPD
by: Oh YM, et al.
Published: (2018-10-01) -
Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts
by: Cheng SL, et al.
Published: (2016-09-01)